Katerzia

Product NDC
52652-5001
11-digit product format
526525001
Labeler code
52652
Product ID
52652-5001_461e8d10-1805-e107-e063-6294a90aa288
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Amlodipine
Dosage form
SUSPENSION
Route
ORAL
Labeler
Azurity Pharmaceuticals, Inc.
Application
NDA211340
Marketing category
NDA
Marketing start
2019-08-15
Substance
AMLODIPINE BENZOATE
Active strength
1 mg/mL
Pharmacologic classes
Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N211340-001KATERZIAAMLODIPINE BENZOATEEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08

Orange Book patents#

Current patent rows page 1 of 1 · 18 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N211340-001108940392037-10-06U-1852021-02-16
N211340-001108940392037-10-06U-32021-02-16
N211340-001109529982037-10-06Drug product2021-03-29
N211340-001109599912037-10-06U-1582021-04-15
N211340-001109599912037-10-06U-392021-04-15
N211340-001113642302037-10-06Drug product2022-06-24
N211340-001114714092037-10-06U-34472022-10-18
N211340-001114714092037-10-06U-34482022-10-18
N211340-001114844982037-10-06Drug product2022-11-04
N211340-001117013262037-10-06Drug product2023-07-20
N211340-001119186852037-10-06U-34472024-03-14
N211340-001119186852037-10-06U-34482024-03-14
N211340-001120534612037-10-06Drug product2024-08-15
N211340-001123369842037-10-06U-34472025-06-27
N211340-001123369842037-10-06U-34482025-06-27
N211340-001123834982037-10-06Drug product2025-10-29
N211340-001106953292037-10-16Drug product2020-07-22
N211340-001107994532039-04-11Drug product2020-11-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-0803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-082680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-085bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-0879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-081e350fbaab3a…
2024-05-31 18:47 UTC2024-05N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-088072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-085c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-085d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-084b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N211340-001KATERZIAEQ 1MG BASE/MLSOLUTION / ORALRLD, RS2019-07-0874a2ff9319b5…
2022-03-09 01:35 UTC2022-03N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-0887673890dc5c…
2021-03-12 10:30 UTC2021-03N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-085aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-088869cabd3fbd…
2020-11-12 02:37 UTC2020-11N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08c0c555d07b60…
2019-12-14 00:12 UTC2019-12N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-083f01610625f2…
2019-09-15 20:21 UTC2019-09N211340-001KATERZIAEQ 1MG BASE/MLSOLUTION / ORALRLD, RS2019-07-08b00525d2431f…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-086a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-081c564ffb4f44…
2023-12-20 04:57 UTC2023-12N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-089b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-083f0d92c62455…
2023-05-13 08:27 UTC2023-05N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08053a50430f4f…
2023-01-26 05:58 UTC2023-01N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-083bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-083a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N211340-001KATERZIAEQ 1MG BASE/MLSUSPENSION / ORALRLD, RS2019-07-08cb3db0bc1861…

Observed Orange Book patent history#

Patent history page 1 of 11 · 434 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-08-18 06:07:402026-07N211340-001108940392037-10-06U-32021-02-16caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001108940392037-10-06U-1852021-02-16caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001109529982037-10-06Drug product2021-03-29caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001109599912037-10-06U-392021-04-15caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001109599912037-10-06U-1582021-04-15caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001113642302037-10-06Drug product2022-06-24caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001114714092037-10-06U-34472022-10-18caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001114714092037-10-06U-34482022-10-18caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001114844982037-10-06Drug product2022-11-04caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001117013262037-10-06Drug product2023-07-20caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001119186852037-10-06U-34472024-03-14caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001119186852037-10-06U-34482024-03-14caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001120534612037-10-06Drug product2024-08-15caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001123369842037-10-06U-34472025-06-27caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001123369842037-10-06U-34482025-06-27caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001123834982037-10-06Drug product2025-10-29caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001106953292037-10-16Drug product2020-07-22caaa826d4ba7…
2026-08-18 06:07:402026-07N211340-001107994532039-04-11Drug product2020-11-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N211340-001108940392037-10-06U-32021-02-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001108940392037-10-06U-1852021-02-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001109529982037-10-06Drug product2021-03-29011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001109599912037-10-06U-392021-04-15011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001109599912037-10-06U-1582021-04-15011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001113642302037-10-06Drug product2022-06-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001114714092037-10-06U-34472022-10-18011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001114714092037-10-06U-34482022-10-18011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001114844982037-10-06Drug product2022-11-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001117013262037-10-06Drug product2023-07-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001119186852037-10-06U-34472024-03-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001119186852037-10-06U-34482024-03-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001120534612037-10-06Drug product2024-08-15011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001123369842037-10-06U-34472025-06-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001123369842037-10-06U-34482025-06-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001123834982037-10-06Drug product2025-10-29011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001106953292037-10-16Drug product2020-07-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N211340-001107994532039-04-11Drug product2020-11-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211340-001108940392037-10-06U-32021-02-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211340-001108940392037-10-06U-1852021-02-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211340-001109529982037-10-06Drug product2021-03-2931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N211340-001109599912037-10-06U-392021-04-1531067a03dcf5…

Additional Listing Data#

Finished product
Yes
Brand name base
Katerzia
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
AMLODIPINE BENZOATE1 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
XD75TQ8A2PInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2184120Internal RxNorm lookup
2184126Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
df673a4d-acb8-444c-a472-c87ab8cbd366Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fa898d56-9495-d6f0-309b-68a5d8e3914aProduct name420260305
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
265792b3-b999-c010-7364-a7db20b9d4d9Product name520250515
14c2c15b-f823-4ada-a40e-a440544294dcProduct name120221207
a72887ef-d675-499f-af4b-78688f6855cdProduct name120191002
a4484670-2869-6416-f6ff-03b1b3cbd1b0Product name220190415
4a27501f-a987-48a5-99b4-e983d4744d76Product name720181211
18600d07-613d-bf9c-2711-fe40c06f3393Product name520180703
bded1554-44de-900a-5297-403365d6d4b2Product name320170110
1f1c6e4b-bbad-4649-afd1-7a1d671db4b1Product name120150316
63ab5fbf-2a6b-c41d-051a-39e845d718b1Product name120140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52652-5001-1Katerzia150 mL in 1 BOTTLESUSPENSION1507
52652-5001-1Katerzia1 in 1 CARTONSUSPENSION17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
52652-5001-1ML - Milliliter52652-50013f707fe7-74e3-4a25-bde4-5a7f4e0e21b312019-08-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52652-5001KATERZIA (AMLODIPINE) SUSPENSION [AZURITY PHARMACEUTICALS, INC.]6Current NDC, Legacy NDC, 2 package rows20230719_df673a4d-acb8-444c-a472-c87ab8cbd366.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KaterziaAMLODIPINEAzurity Pharmaceuticals, Inc.df673a4d-acb8-444c-a472-c87ab8cbd3662025-12-16Warnings, Adverse reactionsExact identifier
application applno (NDA): 211340
application number: NDA211340
ndc (product): 52652-5001

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2184120amLODIPine 1 MG/mL Oral SuspensionPSNdf673a4d-acb8-444c-a472-c87ab8cbd3667
2184126Katerzia 1 MG/mL Oral SuspensionPSNdf673a4d-acb8-444c-a472-c87ab8cbd3667
2184126amlodipine 1 MG/ML Oral Suspension [Katerzia]SBDdf673a4d-acb8-444c-a472-c87ab8cbd3667
2184120amlodipine 1 MG/ML Oral SuspensionSCDdf673a4d-acb8-444c-a472-c87ab8cbd3667
2184120amlodipine 1 MG/ML (as amlodipine benzoate 1.3 MG/ML) Oral SuspensionSYdf673a4d-acb8-444c-a472-c87ab8cbd3667
2184126Katerzia 1 MG/ML Oral SuspensionSYdf673a4d-acb8-444c-a472-c87ab8cbd3667

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
52652-5001-1526525001011 BOTTLE in 1 CARTON (52652-5001-1) / 150 mL in 1 BOTTLE1 bottle2019-08-150000-00-00NoNoCurrent